Research by the Weizmann Institute of Science's Prof. Yardena Samuels shows that heterogeneity in melanoma tumors prevents effective immune responsesArticle Correctness Is Author's Responsibility: Cancer Protocols: A New Approach to Predicting Treatment Outcomes
Research by the Weizmann Institute of Science's Prof. Yardena Samuels shows that heterogeneity in melanoma tumors prevents effective immune responses
